Kershaw RM, Roberts D, Wragg JW, Shaaban AM, Humphreys E, Halsall J, Price L, Bicknell R, Gaston K, Jayaraman PS. Proline-Rich Homeodomain protein (PRH/HHEX) is a suppressor of breast tumour growth. Oncogenesis. 2017; 6:e346.
Wragg JW, Heath V, Bicknell R. Sunitinib Treatment Enhances Metastasis of Innately Drug-Resistant Breast Tumors. Cancer Research. 2017; 77(4).
Wragg JW, Mueller F. Transcriptional regulation during zygotic genome activation in Zebrafish and other anamniote embryos. Genetics, Genomics and Phenomics of Fish. Philadelphia, US: Elsevier; 2016.
Wragg JW, Finnity JP, Anderson JA, Ferguson HJM, Bhatt RI, Murray PG, Heath VL, Bicknell R. MCAM and LAMA4 are highly enriched in tumor blood vessels of renal cell carcinoma and predict patient outcome. Cancer Research. 2016.
Ferguson HJM*, Wragg JW*, Ward S, Ismail T, Adams D, Heath VL, Bicknell R. Vaccination against the novel endothelial marker GRIN2D inhibits angiogenesis and tumour growth in colorectal cancer. Oncotarget. 2016; (epub ahead of print). *(Joint first author).
Wragg JW, Bicknell R. Next generation sequencing in cancer vascular research. European Pharmaceutical Review. 2015;4:10-13.
Wragg JW, Durant S, McGettrick HM, Sample KM, Egginton S, Bicknell R. Shear stress regulated gene expression and angiogenesis in vascular endothelium. Microcirculation. 2014;21:290–300.
Ferguson HJM, Wragg JW, Ismail T, Bicknell R. Vaccination against tumour blood vessels in colorectal cancer. Eur J Surg Oncol. 2014;40:133–6.
, Bicknell R. Vascular targeting approaches to treat cancer. Cancer Targeted Drug Delivery. New York, NY: Springer New York; 2013: 59–95.
View all publications in research portal